Search Results

Filter
  • 1-10 of  75 results for ""Hypolipidemic Agents""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Prevalence of and Factors Associated With the Prescription of Fibrates Among Patients Receiving Lipid-Lowering Drugs in Germany.

  • Authors : Jacob L; Research and Development Unit, Parc Sanitari Sant Joan de Déu, Dr Antoni Pujadas, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.

Subjects: Practice Patterns, Physicians'*; Dyslipidemias/Dyslipidemias/Dyslipidemias/*drug therapy ; Fibric Acids/Fibric Acids/Fibric Acids/*therapeutic use

  • Source: Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2021 Dec 01; Vol. 78 (6), pp. 885-890.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7902492 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Editor's Choice - Optimal Pharmacological Treatment of Symptomatic Peripheral Arterial Occlusive Disease and Evidence of Female Patient Disadvantage: An Analysis of Health Insurance Claims Data.

  • Authors : Peters F; Department of Vascular Medicine, Research Group GermanVasc, University Heart and Vascular Centre Hamburg, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Kreutzburg T

Subjects: Administrative Claims, Healthcare* ; Health Status Disparities*; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use

  • Source: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery [Eur J Vasc Endovasc Surg] 2020 Sep; Vol. 60 (3), pp. 421-429. Publisher: Elsevier Country of Publication: England NLM ID: 9512728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2165

Record details

×
Academic Journal

Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial.

  • Authors : Hermansen K; Department of Medicine and Endocrinology MEA, Aarhus University Hospital, Aarhus, Denmark.; Bækdal TA

Subjects: Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Diet, High-Fat/Diet, High-Fat/Diet, High-Fat/*adverse effects

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2013 Nov; Vol. 15 (11), pp. 1040-8. Date of Electronic Publication: 2013 Jun 11.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The whey fermentation product malleable protein matrix decreases TAG concentrations in patients with the metabolic syndrome: a randomised placebo-controlled trial.

  • Authors : Gouni-Berthold I; Center of Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Kerpener Street 62, 50937 Cologne, Germany. ; Schulte DM

Subjects: Yogurt*/Yogurt*/Yogurt*/adverse effects ; Yogurt*/Yogurt*/Yogurt*/analysis; Carbohydrate Metabolism, Inborn Errors/Carbohydrate Metabolism, Inborn Errors/Carbohydrate Metabolism, Inborn Errors/*prevention & control

  • Source: The British journal of nutrition [Br J Nutr] 2012 Jun; Vol. 107 (11), pp. 1694-706.Publisher: Published on behalf of the Nutrition Society by CABI Publishing Country of Publication: England NLM ID: 0372547 Publication Model: Print Cited

Record details

×
Academic Journal

Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany.

  • Authors : Michailov GV; Outcomes Research Department, MSD Sharp & Dohme GmbH, Haar, Germany. ; Davies GM

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Dyslipidemias/Dyslipidemias/Dyslipidemias/*drug therapy ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*therapeutic use

  • Source: The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2012 Jun; Vol. 13 (3), pp. 365-74. Date of Electronic Publication: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134867 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

How will new medications affect the lipoprotein apheresis situation in Germany?

  • Authors : Parhofer KG; Medical Department II, Grosshadern, University Munich, Marchioninistraße 15, 81377 Munich, Germany.

Subjects: Blood Component Removal*/Blood Component Removal*/Blood Component Removal*/adverse effects; Hyperlipidemias/Hyperlipidemias/Hyperlipidemias/*therapy ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*therapeutic use

  • Source: Atherosclerosis. Supplements [Atheroscler Suppl] 2013 Jan; Vol. 14 (1), pp. 71-2.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100973461 Publication Model: Print Cited Medium: Internet ISSN: 1878-5050

Record details

×
Academic Journal

[Optimal lipid treatment: possibilities and current limitations].

  • Authors : Klose G; Internistische Praxisgemeinschaft Dres. T. Beckenbauer, S. Maierhof, Hans-Thoma-Strasse 31, Bremen, Germany.

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control ; Hypercholesterolemia/Hypercholesterolemia/Hypercholesterolemia/*drug therapy

  • Source: Der Internist [Internist (Berl)] 2011 Mar; Vol. 52 (3), pp. 328-35.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0264620 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Evaluation of the safety and tolerability of prolonged-release nicotinic acid in a usual care setting: the NAUTILUS study.

Subjects: Drug-Related Side Effects and Adverse Reactions*; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*administration & dosage ; Niacin/Niacin/Niacin/*administration & dosage

  • Source: Current medical research and opinion [Curr Med Res Opin] 2006 Feb; Vol. 22 (2), pp. 417-25.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print Cited Medium: Print ISSN: 0300-7995

Record details

×
Academic Journal

Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings.

  • Authors : Mosshammer D; Division of General Medicine, University of Tübingen, Tübingen, Germany. ; Lorenz G

Subjects: Dyslipidemias/Dyslipidemias/Dyslipidemias/*drug therapy ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/*adverse effects ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*adverse effects

  • Source: Family practice [Fam Pract] 2009 Apr; Vol. 26 (2), pp. 88-95. Date of Electronic Publication: 2009 Feb 20.Publisher: Oxford University Press Country of Publication: England NLM ID: 8500875 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

[Guidelines of lipid therapy translation into clinical practice].

Subjects: Guidelines as Topic*; Coronary Artery Disease/Coronary Artery Disease/Coronary Artery Disease/*prevention & control ; Hyperlipidemias/Hyperlipidemias/Hyperlipidemias/*drug therapy

  • Source: Der Internist [Internist (Berl)] 2005 May; Vol. 46 Suppl 1, pp. S11-7.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0264620 Publication Model: Print Cited Medium: Print

Record details

×
  • 1-10 of  75 results for ""Hypolipidemic Agents""